Selective Loss of TGFβ Smad-Dependent Signalling Prevents Cell Cycle Arrest and Promotes Invasion in Oesophageal Adenocarcinoma Cell Lines
Open Access
- 31 January 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (1) , e177
Abstract
In cancer, Transforming Growth Factor β (TGFβ) increases proliferation and promotes invasion via selective loss of signalling pathways. Oesophageal adenocarcinoma arises from Barrett's oesophagus, progresses rapidly and is usually fatal. The contribution of perturbed TGFβ signalling in the promotion of metastasis in this disease has not been elucidated. We therefore investigated the role of TGFβ in Barrett's associated oesophageal adenocarcinoma using a panel of cell lines (OE33, TE7, SEG, BIC, FLO). 4/5 adenocarcinoma cell lines failed to cell cycle arrest, down-regulate c-Myc or induce p21 in response to TGFβ, and modulation of a Smad3/4 specific promoter was inhibited. These hyperproliferative adenocarcinoma cell lines displayed a TGFβ induced increase in the expression of the extracellular matrix degrading proteinases, urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1), which correlated with an invasive cell phenotype as measured by in vitro migration, invasion and cell scattering assays. Inhibiting ERK and JNK pathways significantly reduced PAI and uPA induction and inhibited the invasive cell phenotype. These results suggest that TGFβ Smad-dependent signalling is perturbed in Barrett's carcinogenesis, resulting in failure of growth-arrest. However, TGFβ can promote PAI and uPA expression and invasion through MAPK pathways. These data would support a dual role for TGFβ in oesophageal adenocarcinoma.Keywords
This publication has 37 references indexed in Scilit:
- Inability of Transforming Growth Factor-β to Cause SnoN Degradation Leads to Resistance to Transforming Growth Factor-β–Induced Growth Arrest in Esophageal Cancer CellsCancer Research, 2005
- Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumorsOncogene, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- MEKK1 Is Required for Inducible Urokinase-type Plasminogen Activator ExpressionJournal of Biological Chemistry, 2003
- Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancersBiochemical Society Transactions, 2002
- Phosphatidylinositol 3-Kinase and NF-κB Regulate Motility of Invasive MDA-MB-231 Human Breast Cancer Cells by the Secretion of Urokinase-type Plasminogen ActivatorJournal of Biological Chemistry, 2002
- Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell PopulationsThe American Journal of Pathology, 2002
- Proliferative Activity in Barrett’s Esophagus Before and After Antireflux SurgeryAnnals of Surgery, 2001
- Plasminogen activators in oesophageal carcinomaBritish Journal of Surgery, 1996
- Involvement of a Mitogen-activated Protein Kinase Signaling Pathway in the Regulation of Urokinase Promoter Activity by c-Ha-rasJournal of Biological Chemistry, 1995